Dr Annalisa Masi
She graduated from University of Rome “La Sapienza” in Chemistry (2000) and obtained her Ph.D. in Pharmaceutical Science at University of Rome “La Sapienza” (2006). From 2003 to 2010 she obtained different collaboration grants awarded by The Institute of Crystallography CNR. During her formation and postdoctoral work experience she increased her expertise in the: chemistry of nucleic acids (design, synthesis and characterization), synthesis of the modified phosphoramidites and their use in automatic synthesis, study of the structure-function relationships in proteins and nucleic acids, in their complexes between them and with small molecules. She also studied the action mechanism of the antiviral drugs, the synthesis of the modified phosphoramidites and their use in automatic synthesis of appropriate oligonucleotides. In 2011 she was appointed researcher at the CNR-ISOF in Bologna where she worked on the design and synthesis of bioactive molecules for the study of oxidative DNA damage, enzymatic repair system and biomarkers discovery. Since 2020 she has been working IC-CNR in Rome where she is active in the same research line. Since 2018 she has also been a member of an organizing committee of ECM “Accademia dei Meccanismi Molecolari" (AMM) in Bologna, she was member of the organizing committee of ECM “Aspetti Molecolari di Prevenzione e Salute” in Rome (2016) and ITWIIN Conference Award Bologna (2016). Advisor Board Member of the Rep Eat Programme Grant Agreement (2017). Co-author of 34 papers, 3 book chapters and 20 Abstracts and Posters in Congress.
